AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Nuvation Bio Inc. Director's Dealing 2021

Feb 12, 2021

32154_dirs_2021-02-12_25cc6889-c201-41d6-b37f-b245bcf0d1eb.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2021-02-10

Reporting Person: Templeman Thomas (SVP, Pharmaceutical Ops)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities owned.	0	Direct